174 related articles for article (PubMed ID: 11181883)
41. Executive performance on the preschool executive task assessment in children with sickle cell anemia and matched controls.
Downes M; Kirkham FJ; Berg C; Telfer P; de Haan M
Child Neuropsychol; 2019 Feb; 25(2):278-285. PubMed ID: 29954249
[TBL] [Abstract][Full Text] [Related]
42. Baseline neurocognitive scores in athletes with attention deficit-spectrum disorders and/or learning disability.
Zuckerman SL; Lee YM; Odom MJ; Solomon GS; Sills AK
J Neurosurg Pediatr; 2013 Aug; 12(2):103-9. PubMed ID: 23790088
[TBL] [Abstract][Full Text] [Related]
43. Cognitive and behavioral function in children with sickle cell disease: a review and discussion of methodological issues.
White DA; DeBaun M
J Pediatr Hematol Oncol; 1998; 20(5):458-62. PubMed ID: 9787319
[TBL] [Abstract][Full Text] [Related]
44. Identifying cognitive problems in children and adolescents with depression using computerized neuropsychological testing.
Brooks BL; Iverson GL; Sherman EM; Roberge MC
Appl Neuropsychol; 2010 Jan; 17(1):37-43. PubMed ID: 20146120
[TBL] [Abstract][Full Text] [Related]
45. Social information processing and magnetic resonance imaging in children with sickle cell disease.
Boni LC; Brown RT; Davis PC; Hsu L; Hopkins K
J Pediatr Psychol; 2001; 26(5):309-19. PubMed ID: 11390573
[TBL] [Abstract][Full Text] [Related]
46. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
[TBL] [Abstract][Full Text] [Related]
47. Neuropsychologic and academic functioning of children with sickle cell anemia.
Fowler MG; Whitt JK; Lallinger RR; Nash KB; Atkinson SS; Wells RJ; McMillan C
J Dev Behav Pediatr; 1988 Aug; 9(4):213-20. PubMed ID: 3216001
[TBL] [Abstract][Full Text] [Related]
48. Visual Motor Integration in Children With Sickle Cell Disease.
Newby RF; Epping A; Geiger JA; Miller MS; Scott JP
J Pediatr Hematol Oncol; 2018 Oct; 40(7):495-498. PubMed ID: 30044354
[TBL] [Abstract][Full Text] [Related]
49. Cognitive Abilities Moderate the Effect of Disease Severity on Health-Related Quality of Life in Pediatric Sickle Cell Disease.
Hardy SJ; Bills SE; Wise SM; Hardy KK
J Pediatr Psychol; 2018 Sep; 43(8):882-894. PubMed ID: 29659914
[TBL] [Abstract][Full Text] [Related]
50. Language processing deficits in sickle cell disease in young school-age children.
Schatz J; Puffer ES; Sanchez C; Stancil M; Roberts CW
Dev Neuropsychol; 2009; 34(1):122-36. PubMed ID: 19142770
[TBL] [Abstract][Full Text] [Related]
51. The association between sleep disturbances and neurocognitive function in pediatric sickle cell disease.
Tucker T; Alishlash AS; Lebensburger JD; Clay OJ; Oates GR; Nourani A; Bhatia S; Murdaugh DL
Sleep Med; 2022 Sep; 97():27-35. PubMed ID: 35696755
[TBL] [Abstract][Full Text] [Related]
52. Selective Difficulties in Lexical Retrieval and Nonverbal Executive Functioning in Children With HbSS Sickle Cell Disease.
Arfé B; Montanaro M; Mottura E; Scaltritti M; Manara R; Basso G; Sainati L; Colombatti R
J Pediatr Psychol; 2018 Jul; 43(6):666-677. PubMed ID: 29432593
[TBL] [Abstract][Full Text] [Related]
53. Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study.
Colombatti R; Lucchetta M; Montanaro M; Rampazzo P; Ermani M; Talenti G; Baracchini C; Favero A; Basso G; Manara R; Sainati L
PLoS One; 2016; 11(6):e0157090. PubMed ID: 27281287
[TBL] [Abstract][Full Text] [Related]
54. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
55. Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors.
Montanaro M; Colombatti R; Pugliese M; Migliozzi C; Zani F; Guerzoni ME; Manoli S; Manara R; Meneghetti G; Rampazzo P; Cavalleri F; Giordan M; Paolucci P; Basso G; Palazzi G; Sainati L
Ital J Pediatr; 2013 Jun; 39():36. PubMed ID: 23735165
[TBL] [Abstract][Full Text] [Related]
56. Cognitive screening for silent cerebral infarction in children with sickle cell disease.
White DA; Moinuddin A; McKinstry RC; Noetzel M; Armstrong M; DeBaun M
J Pediatr Hematol Oncol; 2006 Mar; 28(3):166-9. PubMed ID: 16679942
[TBL] [Abstract][Full Text] [Related]
57. Cognitive outcomes of pediatric stroke.
Jacomb I; Porter M; Brunsdon R; Mandalis A; Parry L
Child Neuropsychol; 2018 Apr; 24(3):287-303. PubMed ID: 27960625
[TBL] [Abstract][Full Text] [Related]
58. Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
Berkelhammer LD; Williamson AL; Sanford SD; Dirksen CL; Sharp WG; Margulies AS; Prengler RA
Child Neuropsychol; 2007 Mar; 13(2):120-31. PubMed ID: 17364569
[TBL] [Abstract][Full Text] [Related]
59. Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease.
Armstrong FD; Thompson RJ; Wang W; Zimmerman R; Pegelow CH; Miller S; Moser F; Bello J; Hurtig A; Vass K
Pediatrics; 1996 Jun; 97(6 Pt 1):864-70. PubMed ID: 8657528
[TBL] [Abstract][Full Text] [Related]
60. Attention Deficit Hyperactivity Disorder in Children With Sickle Cell Disease Referred for an Evaluation.
Acquazzino MA; Miller M; Myrvik M; Newby R; Scott JP
J Pediatr Hematol Oncol; 2017 Jul; 39(5):350-354. PubMed ID: 28538513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]